Use of Strattice Mesh in Paraesophageal Hernia Surgery (Strattice)

August 30, 2023 updated by: University of Nebraska

Use of Strattice in the Laparoscopic Suture Closure of a Paraesophageal Hernia

The objective of this study is to examine the safety and efficacy of porcine acellular dermal matrix mesh (Strattice; LifeCell Corp., Branchburg, NJ) in crural reinforcement of laparoscopic large paraesophageal hernia repair.

Study Overview

Detailed Description

Prosthetic reinforcements reduce recurrence rates; the choice of optimal prosthetic, either synthetic or biosynthetic, for crural reinforcement is controversial. The objective of this study is to examine the safety and efficacy of porcine acellular dermal matrix mesh (Strattice; LifeCell Corp., Branchburg, NJ) in crural reinforcement of laparoscopic large paraesophageal hernia repair. Strattice is a commonly used mesh in hernia repair. 35 adult (>19 years of age) patients will be selected based on inclusion and exclusion criteria. Patients who meet the criteria will be enrolled in the study. Information related to recurrence rates based on follow-up visits will be analyzed to determine the efficacy of Strattice in the prevention of large hernia recurrence.

Study Type

Observational

Enrollment (Actual)

35

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Nebraska
      • Omaha, Nebraska, United States, 68198
        • University of Nebraska Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

17 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Adults over 19 years of age with paraesophageal hernia greater than 5 cm.

Description

Inclusion Criteria:

  • Documented symptomatic paraesophageal hernia.
  • Greater than 5 cm hiatal hernia on upper gastrointestinal study.
  • Evidence that the stomach or other viscera is present in the hernia and does not spontaneously reduce from the mediastinum.
  • Significant symptoms or signs of a paraesophageal hernia including but not limited to heartburn, dysphagia, chest pain, shortness of breath, postprandial abdominal pain, early satiety, odynophagia, or chronic anemia.
  • Consenting adult 19 years of age or older
  • Must be able to participate in follow-up evaluation.
  • Free of cognitive impairment

Exclusion Criteria:

  • Children and adolescents (19 years of age or younger).
  • Pregnant and breast feeding patients.
  • Vulnerable subjects such as pregnant women, children less than 19 years age, and decisionally impaired persons.
  • Patients with previous operation of the esophagus or stomach.
  • Patients with associated gastrointestinal diseases that require extensive medical or surgical intervention that might interfere with quality of life assessment (e.g. Crohn's disease).
  • Patients with emergent operation for acute gastric volvulus.
  • Patients with known sensitivity to porcine material.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Documented symptomatic paraesophageal hernia
  1. Documented symptomatic paraesophageal hernia.
  2. Greater than 5 cm hiatal hernia on upper gastrointestinal study.
  3. Evidence that the stomach or other viscera is present in the hernia and does not spontaneously reduce from the mediastinum.
  4. Significant symptoms or signs of a paraesophageal hernia including but not limited to heartburn,dysphagia, chest pain, shortness of breath, postprandial abdominal pain, early satiety, odynophagia, or chronic anemia.
  5. Consenting adult 19 years of age or older
  6. Must be able to participate in follow-up evaluation.
  7. Free of cognitive impairment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hernia recurrence
Time Frame: 1 year post-surgery
A barium swallow test with x-rays will be performed to assess recurrence of hernia, if any
1 year post-surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recurrence of reflux symptoms
Time Frame: 2 weeks, 6 months and 1 year post-surgery
Patients will be evaluated for recurrence of reflux symptoms at the three postoperative visits. If recurrence warrants, a barium swallow with x-rays will be performed prior to 1-year primary outcome barium swallow test
2 weeks, 6 months and 1 year post-surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Dmitry Oleynikov, MD, University of Nebraska

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 5, 2012

Primary Completion (Actual)

May 1, 2015

Study Completion (Actual)

May 1, 2015

Study Registration Dates

First Submitted

August 29, 2012

First Submitted That Met QC Criteria

August 31, 2012

First Posted (Estimated)

September 3, 2012

Study Record Updates

Last Update Posted (Actual)

September 6, 2023

Last Update Submitted That Met QC Criteria

August 30, 2023

Last Verified

August 1, 2023

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hiatal Hernia

3
Subscribe